Evidence map›Paper›PMID 42147640›Full record

ArticleCureus2026

Cellulitis Occurring 21 Years After Radiofrequency Ablation for Breast Cancer: A Case Report.

Tatsunori Higashi, Shoji Oura

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tatsunori HigashiDepartment of Surgery, Kishiwada Tokushukai Hospital, Kishiwada, JPN.
Shoji OuraDepartment of Surgery, Kishiwada Tokushukai Hospital, Kishiwada, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 67-year-old woman had undergone radiofrequency ablation (RFA) for right breast cancer at a university hospital 21 years before and visited our hospital for annual breast surveillance after finishing the 10-year follow-up. During the annual breast surveillance, unexplained and unintentional weight loss made the subcutaneous fat just above the RFA nodule thin. It caused cellulitis due to the RFA nodule-related stimuli to the overlying skin. Image evaluation clarified the strong adhesion between the RFA nodule and the overlying skin. After recovery from cellulitis, the patient requested resection of the RFA nodule to prevent recurrence. The patient, however, already had marked asymmetry of the breasts due to the radiation-induced shrinkage of the right breast. The patient, therefore, underwent breast surgeries as follows to get better cosmetic outcomes. The patient underwent RFA nodule resection via a retromammary space approach through a lateral vertical skin incision, achieving a difficult but successful complete removal of the RFA nodule. After that, the shrunken and hard right mammary gland was partially incised in several linear fashions from the retromammary space, followed by immediate breast augmentation using the latissimus dorsi musculocutaneous flap. Additionally, the left breast was treated with inverted T reduction mammoplasty, successfully leading to the favorable cosmesis of the breasts. The patient recovered uneventfully, is fully satisfied with the cosmetic outcomes of her breasts after the operation, and is scheduled to further receive annual breast surveillance on an outpatient basis. Breast surgeons should note that the RFA indication for breast cancer should not only include breast cancer characteristics but also late and aging-related complications.

Indexed as

breast cancercellulitisdystrophic calcificationslate complicationsradiofrequency ablation

Identifiers

PMID42147640
PMCPMC13176791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.